BlackRock’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$129M Sell
12,975,299
-253,203
-2% -$2.27M ﹤0.01% 1952
2025
Q4
$112M Sell
13,228,502
-530,880
-4% -$3.79M ﹤0.01% 2039
2025
Q3
$71.8M Sell
13,759,382
-195,104
-1% -$744K ﹤0.01% 2286
2025
Q2
$48.3M Sell
13,954,486
-524,312
-4% -$1.56M ﹤0.01% 2467
2025
Q1
$37.9M Sell
14,478,798
-195,464
-1% -$766K ﹤0.01% 2526
2024
Q4
$60.5M Buy
14,674,262
+2,932,115
+25% +$16M ﹤0.01% 2343
2024
Q3
$83.1M Buy
11,742,147
+1,199,480
+11% +$8.96M ﹤0.01% 2188
2024
Q2
$68.7M Buy
10,542,667
+746,457
+8% +$5.1M ﹤0.01% 2244
2024
Q1
$81.3M Buy
9,796,210
+222,787
+2% +$2.17M ﹤0.01% 2172
2023
Q4
$105M Buy
9,573,423
+1,243,656
+15% +$10.5M ﹤0.01% 2040
2023
Q3
$70.1M Sell
8,329,767
-37,961
-0.5% -$408K ﹤0.01% 2195
2023
Q2
$105M Buy
8,367,728
+432,038
+5% +$5.37M ﹤0.01% 2014
2023
Q1
$131M Sell
7,935,690
-62,295
-0.8% -$1.12M ﹤0.01% 1851
2022
Q4
$119M Buy
7,997,985
+1,240,348
+18% +$23.7M ﹤0.01% 1880
2022
Q3
$151M Buy
6,757,637
+180,459
+3% +$3.96M 0.01% 1684
2022
Q2
$110M Buy
6,577,178
+602,995
+10% +$12.9M ﹤0.01% 1945
2022
Q1
$179M Sell
5,974,183
-19,430
-0.3% -$471K ﹤0.01% 1749
2021
Q4
$184M Buy
5,993,613
+641,001
+12% +$20.3M ﹤0.01% 1793
2021
Q3
$169M Buy
5,352,612
+812,282
+18% +$27.3M ﹤0.01% 1847
2021
Q2
$166M Buy
4,540,330
+741,600
+20% +$24.4M ﹤0.01% 1913
2021
Q1
$131M Buy
3,798,730
+641,756
+20% +$27.9M ﹤0.01% 2019
2020
Q4
$131M Buy
3,156,974
+1,091,529
+53% +$49.3M ﹤0.01% 1907
2020
Q3
$88M Buy
+2,065,445
New +$78.8M ﹤0.01% 1958

Other funds holding RLAY